Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (581-590 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|June 4, 2019
Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily membersYanli Yang, Sherry H Yeh, Shravan Madireddi, et al.
Mabs|May 3, 2019
Attenuated glutamine synthetase as a selection marker in CHO cells to efficiently isolate highly productive stable cells for the production of antibodies and other biologicsPao-Chun Lin, Kah Fai Chan, Irene A Kiess, et al.
Mabs|May 3, 2019
Targets for MAbs: innovative approaches for their discovery & validation, LabEx MAbImprove 6<sup>th</sup> antibody industrial symposium, June 25-26, 2018, Montpellier, FrancePierre Martineau, Hervé Watier, Andre Pèlegrin, et al.
Mabs|May 10, 2019
Retrospective analysis of model-based predictivity of human pharmacokinetics for anti-IL-36R monoclonal antibody MAB92 using a rat anti-mouse IL-36R monoclonal antibody and RNA expression data (FANTOM5)Jennifer Ahlberg, Craig Giragossian, Hua Li, et al.
Mabs|May 21, 2019
A comprehensive search of functional sequence space using large mammalian display libraries created by gene editingKothai Parthiban, Rajika L Perera, Maheen Sattar, et al.
Mabs|March 16, 2022
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodiesRahmad Akbar, Habib Bashour, Puneet Rawat, et al.
Mabs|March 16, 2022
Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variantsTaichi Kuramochi, Siok Wan Gan, Adrian W S Ho, et al.
Mabs|January 18, 2021
Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumorsAdam R Root, Gurkan Guntas, Madan Katragadda, et al.
Mabs|August 13, 2019
Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopesXiao Xiao, Aimin Tang, Kara S Cox, et al.
Mabs|March 29, 2011
6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, SwitzerlandAlain Beck, Thierry Wurch, Janice M Reichert
Pageof 184

Showing results (581-590 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|June 4, 2019
Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily membersYanli Yang, Sherry H Yeh, Shravan Madireddi, et al.
Mabs|May 3, 2019
Attenuated glutamine synthetase as a selection marker in CHO cells to efficiently isolate highly productive stable cells for the production of antibodies and other biologicsPao-Chun Lin, Kah Fai Chan, Irene A Kiess, et al.
Mabs|May 3, 2019
Targets for MAbs: innovative approaches for their discovery & validation, LabEx MAbImprove 6<sup>th</sup> antibody industrial symposium, June 25-26, 2018, Montpellier, FrancePierre Martineau, Hervé Watier, Andre Pèlegrin, et al.
Mabs|May 10, 2019
Retrospective analysis of model-based predictivity of human pharmacokinetics for anti-IL-36R monoclonal antibody MAB92 using a rat anti-mouse IL-36R monoclonal antibody and RNA expression data (FANTOM5)Jennifer Ahlberg, Craig Giragossian, Hua Li, et al.
Mabs|May 21, 2019
A comprehensive search of functional sequence space using large mammalian display libraries created by gene editingKothai Parthiban, Rajika L Perera, Maheen Sattar, et al.
Mabs|March 16, 2022
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodiesRahmad Akbar, Habib Bashour, Puneet Rawat, et al.
Mabs|March 16, 2022
Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variantsTaichi Kuramochi, Siok Wan Gan, Adrian W S Ho, et al.
Mabs|January 18, 2021
Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumorsAdam R Root, Gurkan Guntas, Madan Katragadda, et al.
Mabs|August 13, 2019
Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopesXiao Xiao, Aimin Tang, Kara S Cox, et al.
Mabs|March 29, 2011
6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, SwitzerlandAlain Beck, Thierry Wurch, Janice M Reichert
Pageof 184